Dynamic of plasma IL-22 level is an indicator of thymic output after allogeneic hematopoietic cell transplantation
Dynamic of plasma IL-22 level is an indicator of thymic output after allogeneic hematopoietic cell transplantation
复制标题
血浆IL-22水平动态是异基因造血细胞移植后胸腺输出的指标
DOI:
10.1016/j.lfs.2020.118849
复制
发表时间:
2021-01-15
期刊:
影响因子:
6.1
通讯作者:
Pan,Bin
中科院分区:
文献类型:
--
作者:
Shang,Longmei;Duah,Maxwell;Pan,Bin
AimsInterleukin-22 (IL-22) promotes thymus recovery and improves T-cell recovery in preclinical allogeneic hematopoietic cell transplant models. However, the correlation between IL-22 and thymus recovery is unknown in human transplant.Materials and methodsIn this study, plasma IL-22 levels of transplanted humans were analyzed peri-transplant. Thymic output was assessed by detecting blood signal joint T-cell receptor excision circles (TRECs). Flow cytometry was applied to measure T-cell subsets.Key findingsPlasma IL-22 level positively correlated with blood TRECs level at days 14 and 28 posttransplant. Multiple linear regression analysis showed plasma IL-22 level, occurrence of acute graft-versus-host disease (aGVHD) and age were significantly associated with blood TRECs level at day 28 after allotransplant. An increase of plasma IL-22 level during day 14 and day 28 correlated with faster recovery of blood TRECs and naïve T-cell levels in allotransplant recipients. Recipients with high TRECs levels at day 28 had lower incidence of aGVHD comparing with those who with low TRECs levels according to a median split of their TRECs levels, an effect also seen in the high IL-22 level and low IL-22 level cohorts. Other factors such as age and infection had impacts on plasma IL-22 level in allotransplants.SignificanceOur findings suggest that dynamic change of plasma IL-22 level is an indicator of thymic output and occurrence of aGVHD. Monitoring plasma IL-22 level might help to assess recovery of thymus function in human allotransplants.